Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
LSD Just Passed Its Biggest Trial Yet for Anxiety (gizmodo.com)
2.
Man Accused of Horrific Crimes Caught Hiding as Pharma Executive (futurism.com)
3.
Bizarre CRISPR enzyme kills cancer cells by shredding their DNA (feeds.nature.com)
4.
The Race to Commercialize the World’s Most Powerful Psychedelic (feeds.content.dowjones.io)
5.
Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up to $600 Million (feeds.content.dowjones.io)
6.
Takeda, InSilico Strike AI Drug-Discovery Deal Worth Up to $600 Million (feeds.content.dowjones.io)
7.
Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million (feeds.content.dowjones.io)
8.
Harmonizing standards and resources for the medical genome (feeds.nature.com)
9.
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion (feeds.content.dowjones.io)
10.
LSD Just Passed Its Biggest Test Yet for Treating Depression (gizmodo.com)
11.
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash (feeds.content.dowjones.io)
12.
Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal (feeds.content.dowjones.io)
13.
Developers: Get Your Medical Mobile App Verified By IEEE (spectrum.ieee.org)
14.
Varda’s First Pharma Deal Brings Space Drugs Closer to Reality (gizmodo.com)
15.
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion (feeds.content.dowjones.io)
16.
UCB to Buy Candid Therapeutics for Up to $2.2 Billion (feeds.content.dowjones.io)
17.
Eli Lilly Strikes Deal for Cancer Biotech (feeds.content.dowjones.io)
18.
Eli Lilly Nears Deal for Cancer Biotech (feeds.content.dowjones.io)
19.
Neurocrine to Buy Soleno for Treatment for Rare Disease That Causes Relentless Hunger (feeds.content.dowjones.io)
20.
Neurocrine to Buy Soleno for $2.9 Billion (feeds.content.dowjones.io)
21.
HN: I simulated a real cancer case and predicted why some tumors didn't respond (news.ycombinator.com)
22.
The most innovative biotech companies of 2026 (feeds.feedburner.com)
23.
A gene-editing method generates immunotherapeutic CAR T cells in the body (feeds.nature.com)
24.
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion (feeds.content.dowjones.io)
25.
A skin-permeable polymer for non-invasive transdermal insulin delivery (feeds.nature.com)
Today's top topics: anthropic disney openai apple marvel star wars claude x-men intel android
View all today's topics →